MGRM
Monogram Orthopaedics Inc.
6.00$
-1.8%
vs. previous close
Closing price · As of: Jul 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 82.2% | 78.1% | 89.4% | 88.6% | 87.3% | 85.4% | 82.7% | 92.1% | 91.6% | 90.2% | 89.7% | |
| – | 76.5% | 72.9% | 82.6% | 81.6% | 82.0% | 80.4% | 74.4% | 81.9% | 88.1% | 86.4% | 85.6% | |
| – | 76.5% | 72.9% | 82.6% | 81.6% | 82.0% | 80.4% | 74.4% | 81.9% | 88.1% | 86.4% | 85.6% | |
| – | 1.2% | 0.0% | 4.3% | 0.9% | 2.2% | 0.0% | 1.4% | 6.8% | 0.0% | 0.0% | 0.6% | |
| – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 3.0% | 1.4% | 1.6% | 1.9% | 1.9% | |
| – | 12.2% | 15.2% | 7.5% | – | – | – | – | – | – | – | – | |
| – | 9.5% | 6.7% | 3.2% | 3.3% | 3.3% | 4.0% | 4.5% | 1.9% | 1.9% | 1.9% | 1.6% | |
| – | 69.7% | 92.4% | 41.1% | 34.9% | 19.2% | 18.5% | 28.3% | 13.9% | 18.4% | 23.9% | 42.5% | |
| – | 66.1% | 88.0% | 39.0% | 32.7% | 17.0% | 15.8% | 25.3% | 12.6% | 8.7% | 12.9% | 41.5% | |
| – | 0.9% | 1.1% | 0.6% | 0.7% | 0.8% | 1.0% | 1.4% | 1.3% | 1.6% | 1.8% | 1.0% | |
| – | 4.8% | 11.1% | 7.0% | 9.8% | 14.9% | 10.5% | 17.0% | 7.6% | 6.6% | 7.7% | 8.8% | |
| – | 30.3% | 7.6% | 58.9% | 65.1% | 80.8% | 81.5% | 71.7% | 86.1% | 81.6% | 76.1% | 57.5% | |
| – | -275.8% | -393.1% | -226.2% | -262.4% | -310.7% | -438.7% | -596.5% | -315.0% | -382.6% | -464.8% | -513.5% | |
| – | 70.7% | 276.3% | 93.0% | 160.7% | 189.0% | 251.4% | 321.5% | 159.3% | 183.3% | 229.3% | 236.8% |
Data as of: July 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.